NexImmune Stock (NASDAQ: NEXI) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 337.000 / 614.794K |
Day Range | - - - |
52 Wk Range | 1.250 - 28.695 |
Market Cap | $4.799M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 38 |
Short Interest | 1.45% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of NexImmune (NASDAQ: NEXI) through any online brokerage.
Other companies in NexImmune’s space includes: Alzamend Neuro (NASDAQ:ALZN), Tharimmune (NASDAQ:THAR), Synaptogenix (NASDAQ:SNPX), Geovax Labs (NASDAQ:GOVX) and Finch Therapeutics Gr (NASDAQ:FNCH).
The latest price target for NexImmune (NASDAQ: NEXI) was reported by Cantor Fitzgerald on Wednesday, November 16, 2022. The analyst firm set a price target for 0.00 expecting NEXI to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
The stock price for NexImmune (NASDAQ: NEXI) is $3.5 last updated April 22, 2024 at 5:41 PM EDT.
There are no upcoming dividends for NexImmune.
NexImmune’s Q1 earnings are confirmed for Monday, May 13, 2024.
There is no upcoming split for NexImmune.
NexImmune is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.